Monoclonal Antibody to Dehydroepiandrosterone (DHEA)
- UOM
- FOB US$ 152.00 US$ 356.00 US$ 508.00 US$ 1,270.00 US$ 5,080.00
- Quantity
Overview
Properties
- Product No.MAA398Ge22
- Organism SpeciesPan-species (General) Same name, Different species.
- ApplicationsELISA, CLIA. / IHC-Fr, ICC, IP (predicted).
If the antibody is used in flow cytometry, please check FCM antibodies.
Research use only - DownloadInstruction Manual
- CategoryEndocrinologyReproductive scienceHormone metabolismRheumatology
- SourceMonoclonal antibody preparation, Host Mouse
- Ig Isotype IgG2a Kappa, Clone Number 2-C5
- PurificationProtein A + Protein G affinity chromatography
- LabelNone
- Immunogen CPA398Ge11-BSA Conjugated Dehydroepiandrosterone (DHEA)
- Buffer FormulationPBS, pH7.4, containing 0.02% NaN3, 50% glycerol.
- TraitsLiquid, Concentration 1mg/mL
Sign into your account
Share a new citation as an author
Upload your experimental result
Review

Contact us
Please fill in the blank.
Specifity
The antibody is a mouse monoclonal antibody raised against DHEA. It has been selected for its ability to recognize DHEA in ELISA and CLIA.
Usage
Immunohistochemistry: 5-20µg/mL;
Immunocytochemistry: 5-30µg/mL
Optimal working dilutions must be determined by end user.
Storage
Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.
Stability
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.
Giveaways
Increment services
Citations
- Possible Metabolic Alterations among Autistic Male Children: Clinical and Biochemical ApproachesPubmed: 30600432
- A preliminary study on the mechanism of the neurosteroid-mediated ionotropic receptor dysfunction in neurodevelopmental toxicity induced by?¡33862428
- MiR-1224-5p attenuates polycystic ovary syndrome through inhibiting NOD-like receptor protein 3 inflammasome activation via targeting Forkhead box O 134637688